Klocker H - Search Results

1

Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells.

Heidegger I, Ofer P, Doppler W, Rotter V, Klocker H, Massoner P. Heidegger I, et al. Among authors: klocker h. Endocrinology. 2012 Oct;153(10):4633-43. doi: 10.1210/en.2012-1348. Epub 2012 Aug 17. Endocrinology. 2012. PMID: 22903612

2

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H, Konwalinka G. Culig Z, et al. Among authors: klocker h. Br J Cancer. 1998 Oct;78(8):1004-11. doi: 10.1038/bjc.1998.619. Br J Cancer. 1998. PMID: 9792142 Free PMC article.

3

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H. Putz T, et al. Among authors: klocker h. Cancer Res. 1999 Jan 1;59(1):227-33. Cancer Res. 1999. PMID: 9892211

4

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.

Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z. Cronauer MV, et al. Among authors: klocker h. Br J Cancer. 2000 Jan;82(1):39-45. doi: 10.1054/bjoc.1999.0874. Br J Cancer. 2000. PMID: 10638964 Free PMC article.

5

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.

Eder IE, Culig Z, Ramoner R, Thurnher M, Putz T, Nessler-Menardi C, Tiefenthaler M, Bartsch G, Klocker H. Eder IE, et al. Among authors: klocker h. Cancer Gene Ther. 2000 Jul;7(7):997-1007. doi: 10.1038/sj.cgt.7700202. Cancer Gene Ther. 2000. PMID: 10917202

6

Expression and function of androgen receptor in carcinoma of the prostate.

Culig Z, Hobisch A, Bartsch G, Klocker H. Culig Z, et al. Among authors: klocker h. Microsc Res Tech. 2000 Dec 1;51(5):447-55. doi: 10.1002/1097-0029(20001201)51:5<447::AID-JEMT7>3.0.CO;2-M. Microsc Res Tech. 2000. PMID: 11074615 Review.

7

Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.

Doppler W, Windegger M, Soratroi C, Tomasi J, Lechner J, Rusconi S, Cato AC, Almlöf T, Liden J, Okret S, Gustafsson JA, Richard-Foy H, Starr DB, Klocker H, Edwards D, Geymayer S. Doppler W, et al. Among authors: klocker h. Mol Cell Biol. 2001 May;21(9):3266-79. doi: 10.1128/MCB.21.9.3266-3279.2001. Mol Cell Biol. 2001. PMID: 11287629 Free PMC article.

8

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.

Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: klocker h. Clin Cancer Res. 2001 Sep;7(9):2941-8. Clin Cancer Res. 2001. PMID: 11555613

9

Androgen receptors in prostate cancer.

Culig Z, Klocker H, Bartsch G, Hobisch A. Culig Z, et al. Among authors: klocker h. Endocr Relat Cancer. 2002 Sep;9(3):155-70. doi: 10.1677/erc.0.0090155. Endocr Relat Cancer. 2002. PMID: 12237244 Review.

10

Androgen receptors in prostate cancer.

Culig Z, Klocker H, Bartsch G, Steiner H, Hobisch A. Culig Z, et al. Among authors: klocker h. J Urol. 2003 Oct;170(4 Pt 1):1363-9. doi: 10.1097/01.ju.0000075099.20662.7f. J Urol. 2003. PMID: 14501770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page